BR9105371A - Formulacao apropriada para a administracao transdermica de dobutamina e processo para aumentar a contratilidade cardiaca - Google Patents

Formulacao apropriada para a administracao transdermica de dobutamina e processo para aumentar a contratilidade cardiaca

Info

Publication number
BR9105371A
BR9105371A BR919105371A BR9105371A BR9105371A BR 9105371 A BR9105371 A BR 9105371A BR 919105371 A BR919105371 A BR 919105371A BR 9105371 A BR9105371 A BR 9105371A BR 9105371 A BR9105371 A BR 9105371A
Authority
BR
Brazil
Prior art keywords
contratility
dobutamine
transdermal administration
appropriate formulation
increase cardiac
Prior art date
Application number
BR919105371A
Other languages
English (en)
Inventor
Kirti Himatlal Valia
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9105371A publication Critical patent/BR9105371A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
BR919105371A 1990-12-20 1991-12-12 Formulacao apropriada para a administracao transdermica de dobutamina e processo para aumentar a contratilidade cardiaca BR9105371A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63048090A 1990-12-20 1990-12-20

Publications (1)

Publication Number Publication Date
BR9105371A true BR9105371A (pt) 1992-08-25

Family

ID=24527346

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919105371A BR9105371A (pt) 1990-12-20 1991-12-12 Formulacao apropriada para a administracao transdermica de dobutamina e processo para aumentar a contratilidade cardiaca

Country Status (12)

Country Link
EP (1) EP0492930A3 (pt)
JP (1) JPH04275219A (pt)
KR (1) KR920011479A (pt)
AU (1) AU8985791A (pt)
BR (1) BR9105371A (pt)
CA (1) CA2057647A1 (pt)
CS (1) CS379491A3 (pt)
HU (1) HU914012D0 (pt)
IE (1) IE914453A1 (pt)
IL (1) IL100367A0 (pt)
MX (1) MX9102627A (pt)
ZA (1) ZA919853B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2688288T3 (es) * 2011-02-15 2018-10-31 Elanco Us Inc. Procedimientos para controlar el dolor en caninos utilizando una solución transdérmica de fentanilo

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4704407A (en) * 1984-12-20 1987-11-03 Eli Lilly And Company Soluble dobutamine salts
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
US4814173A (en) * 1987-09-08 1989-03-21 Warner-Lambert Company Silicone elastomer transdermal matrix system

Also Published As

Publication number Publication date
AU8985791A (en) 1992-06-25
CA2057647A1 (en) 1992-06-21
KR920011479A (ko) 1992-07-24
MX9102627A (es) 1992-06-01
IE914453A1 (en) 1992-07-01
ZA919853B (en) 1993-06-14
CS379491A3 (en) 1992-07-15
IL100367A0 (en) 1992-09-06
HU914012D0 (en) 1992-03-30
EP0492930A2 (en) 1992-07-01
EP0492930A3 (en) 1992-10-14
JPH04275219A (ja) 1992-09-30

Similar Documents

Publication Publication Date Title
IT7849523A0 (it) 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
PT88261A (pt) Processo para a preparacao de nucleosidos com efeito terapeutico
BR8900357A (pt) Composicao e processo de tratamento de tecido e processo para a preparacao da dita composicao
ES491432A0 (es) Procedimiento para obtener agentes de tratamiento de fibras queratinicas
DE69218932T2 (de) Transdermale therapeutische Formulierung
BR9004333A (pt) Composicao herbicida e processo para produzir os compostos ativos utilizaveis na mesma
IT7967650A0 (it) Procedimento per la preparazione delle acril e metacril ammidi n.sostituite
DK90089A (da) Hudbehandlingspraeparat
BR8905268A (pt) Composicao e processo para amaciar tecidos
PT84144B (pt) Processo para a preparacao de sulfonamidas heterociclicas uteis como agente antialergicos e antitromboticos
BR7804613A (pt) Acidos imidazol-carboxilicos e seus derivados,processo para a sua preparacao,agente,e aplicacao dos ditos compostos
IT1106176B (it) Derivati di pirrolo loro procedimento di preparazione e loro applicazione terapeutica
IT7849859A0 (it) Derivati di 2-benzoil-4-cloro-glici nanilidi sostituite loro procedimento di preparazione e loro applicazione terapeutica
ES495091A0 (es) Procedimiento de preparacion de una composicion cosmetica destinada a ser utilizada para el tratamiento de materias queratinicas
BR9205077A (pt) Composicao para tratamento dos labios e processo para preparar a mesma
BR8904400A (pt) Processo para a preparacao de uma formulacao pesticida
KR890701004A (ko) 개선된 생리효과를 가지는 식물의 제조 및 이 식물의 용도
BR9001484A (pt) Composicao inseticida e acaricida com efeito aperfeicoado,processo para aperfeicoar o efeito de uma substancia ativa inseticida
BR9105371A (pt) Formulacao apropriada para a administracao transdermica de dobutamina e processo para aumentar a contratilidade cardiaca
IT1096906B (it) Derivati di 1,2,4-ossadiazolo,loro preparazione e loro applicazione in terapia
BR9004202A (pt) Composicoes microbicidas e processo para preparar esteres iodopropargilicos de derivados de alfa-aminoacidos
BR9103197A (pt) Processo e aparelho para aplicar uma substancia a um artigo
BR7801890A (pt) Processo para estabilizar formulacoes purificadas de ar;formulacao purificadora de ar;processo para evitar ou para eleminar essencialmente a vaporizacao e redoposicao de oleos essenciais
BR7807425A (pt) 2,4-diamino-5-benzil-pirimidinas processo para sua preparacao,preservacoes farmaceuticas,aplicacao das ditas benzil-pirimidinas e aldeidos